Concepedia

Robin Frye

RF

16

Publications

1.8K

Citations

14

H-Index

2004

Active since

Affiliations

National Cancer Institute(Current)

Center for Cancer Research

North Shore University Hospital

Peter MacCallum Cancer Centre

City Of Hope National Medical Center

Robin Frye is an author at National Cancer Institute specializing in pathology, immunology, and medicine.

Top concepts

Publications per year

2004–2013

16

Publications

16

Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma

Richard Piekarz, Robin Frye, Maria L. Turner et al. · Journal of Clinical Oncology · 2009 · 728 citations · Full text

, , +18

Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma

Richard Piekarz, Robin Frye, H. Miles Prince et al. · Blood · 2011 · 476 citations · Full text

Randomized, Double-Blind, Placebo-Controlled Phase IIB Trial of the Cyclooxygenase Inhibitor Ketorolac as an Oral Rinse in Oropharyngeal Leukoplakia

James L. Mulshine, Jane C. Atkinson, Robert O. Greer et al. · Clinical Cancer Research · 2004 · 102 citations · Full text

Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T‐cell lymphoma

Susan E. Bates, Zhirong Zhan, Kenneth Steadman et al. · British Journal of Haematology · 2009 · 77 citations · Full text

, , +17

Population Pharmacokinetics of Romidepsin in Patients with Cutaneous T-Cell Lymphoma and Relapsed Peripheral T-Cell Lymphoma

Sukyung Woo, Erin R. Gardner, Xiaohong Chen et al. · Clinical Cancer Research · 2009 · 74 citations · Full text

Rows per page

1–5 of 16